Wolverine Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Wolverine Asset Management’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,244	Closed	-$119K	–	1989
2020 Q4	$119K	Buy	+2,244	New	+$111K	﹤0.01%	1184
2020 Q3	–	Sell	-40	Closed	-$1K	–	1543
2020 Q2	$1K	Buy	+40	New	+$1.92K	﹤0.01%	1485
2016 Q1	–	Sell	-850	Closed	-$30K	–	1198
2015 Q4	$30K	Hold	850	–	–	﹤0.01%	1236
2015 Q3	$28K	Buy	+850	New	+$35.4K	﹤0.01%	1405
2014 Q1	–	Sell	-18,600	Closed	-$464K	–	2330
2013 Q4	$464K	Buy	18,600 +10,000	+116%	+$236K	0.01%	802
2013 Q3	$236K	Buy	8,600 +3,600	+72%	+$75.3K	0.01%	1093
2013 Q2	$90K	Buy	+5,000	New	+$68.9K	﹤0.01%	1464

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Wolverine Asset Management's ACAD Position: Q1 2021 in Review

Wolverine Asset Management sold out of Acadia Pharmaceuticals (ACAD) in Q1 2021, closing a stake of 2,244 shares — an estimated $119K sold.

Wolverine Asset Management first reported a position in ACAD in Q2 2013 and held it in 7 quarters. The position peaked at $464K in Q4 2013. 272 funds tracked by Wall St. Rank hold ACAD as of Q1 2021.

Wolverine Asset Management reported no remaining Acadia Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
Wolverine Asset Management sold 2,244 Acadia Pharmaceuticals shares in Q1 2021, an estimated $119K.
Wolverine Asset Management first reported a position in Acadia Pharmaceuticals in Q2 2013 and held it in 7 quarters.
Wolverine Asset Management's Acadia Pharmaceuticals position peaked at $464K in Q4 2013.
272 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2021.

Based on Wolverine Asset Management's 13F filing for Q1 2021, filed 13 May 2021.